These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16251815)

  • 1. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
    Reichenberg A; Gorman JM; Dieterich DT
    AIDS; 2005 Oct; 19 Suppl 3():S174-8. PubMed ID: 16251815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.
    Raison CL; Borisov AS; Broadwell SD; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
    J Clin Psychiatry; 2005 Jan; 66(1):41-8. PubMed ID: 15669887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Mahajan S; Avasthi A; Grover S; Chawla YK
    J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
    Chapman J; Oser M; Hockemeyer J; Weitlauf J; Jones S; Cheung R
    Am J Gastroenterol; 2011 Dec; 106(12):2123-32. PubMed ID: 21826113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
    Quarantini LC; Bressan RA; Galvão A; Batista-Neves S; Paraná R; Miranda-Scippa A
    Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-induced depression in patients with hepatitis C: an epidemiologic study.
    Medeiros LP; Kayo M; Medeiros RB; Lima MB; Mello CE
    Rev Assoc Med Bras (1992); 2014; 60(1):35-9. PubMed ID: 24918850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated interferon pharmacokinetics and self-reported depressive symptoms during antiviral treatment for chronic hepatitis C.
    Evon DM; Esserman DE; Howell MA; Ruffin RA
    Pharmacopsychiatry; 2014 Sep; 47(6):195-201. PubMed ID: 25121993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    J Clin Psychiatry; 2003 Jun; 64(6):708-14. PubMed ID: 12823087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
    Vabo IL; Ferreira LE; Pace FH
    Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality.
    Castellvi P; Navinés R; Gutierrez F; Jiménez D; Márquez C; Subirà S; Solà R; Martín-Santos R
    J Clin Psychiatry; 2009 Jun; 70(6):817-28. PubMed ID: 19573480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Małyszczak K; Inglot M; Frydecka D; Hadryś T; Pawłowski T
    Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.
    Loftis JM; Patterson AL; Wilhelm CJ; McNett H; Morasco BJ; Huckans M; Morgan T; Saperstein S; Asghar A; Hauser P
    J Psychosom Res; 2013 Jan; 74(1):57-63. PubMed ID: 23272989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska.
    Banjac V; Zivlak-Radulovic N; Miskovic M
    Med Arch; 2016 Apr; 70(2):127-30. PubMed ID: 27147788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study.
    Lieb K; Engelbrecht MA; Gut O; Fiebich BL; Bauer J; Janssen G; Schaefer M
    Eur Psychiatry; 2006 Apr; 21(3):204-10. PubMed ID: 16632167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
    Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadalà G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F
    J Clin Gastroenterol; 2010 Oct; 44(9):e210-7. PubMed ID: 20838237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
    Fontana RJ; Bieliauskas LA; Lindsay KL; Back-Madruga C; Wright EC; Snow KK; Lok AS; Kronfol Z; Padmanabhan L;
    Hepatology; 2007 May; 45(5):1154-63. PubMed ID: 17465000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.